Chromition Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.26M
Latest Deal Amount
  • Investors
  • 5

Chromition General Information

Description

Developer of a digital histopathology screening platform intended to detect cancer in a single tissue biopsy. The company's platform provides a digital multi-colored image of the tissue biopsy which is analysed by a software that assists the clinical decision making process of diagnosis, enabling physicians to take targeted decisions regarding treatments and have high success rate of patient outcome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
  • Greenheys Building
  • Pencroft Way
  • Manchester M15 6JJ
  • England, United Kingdom

Chromition Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chromition Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 27-Nov-2018 $1.26M 00000 Completed Generating Revenue
6. Grant 23-Oct-2018 000.00 00000 Completed Generating Revenue
5. Early Stage VC 21-Dec-2017 00000 00000 00.000 Completed Generating Revenue
4. Early Stage VC 20-Dec-2016 00000 00000 00.000 Completed Startup
3. Seed Round 01-Apr-2016 00000 00000 00.000 Completed Startup
2. Accelerator/Incubator $158K Completed Startup
1. Seed Round 31-Jul-2015 $158K $158K 00000 Completed Startup
To view Chromition’s complete valuation and funding history, request access »

Chromition Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
A Ordinary 2,333 $0.013389 $100.42 $100.42 1x $100.42 13.68%
Ordinary 1,990 $0.013389 $68.31 $68.31 1x $68.31 11.67%
To view Chromition’s complete cap table history, request access »

Chromition Executive Team (2)

Name Title Board Seat Contact Info
Mark McCairn Ph.D Co-Founder, Chief Executive Officer & Board Member
Michael Turner Ph.D Co-Founder, Board Member, Scientific & Technical Advisor
To view Chromition’s complete executive team members history, request access »

Chromition Board Members (5)

Name Representing Role Since
Mark Frost Chromition Chairman 000 0000
Mark McCairn Ph.D Chromition Co-Founder, Chief Executive Officer & Board Member 000 0000
Michael Turner Ph.D Chromition Co-Founder, Board Member, Scientific & Technical Advisor 000 0000
Perry van Rijsingen Self Board Member & Strategic Advisor 000 0000
To view Chromition’s complete board members history, request access »

Chromition Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SBRI Healthcare Government 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
MTI Partners Venture Capital Minority 000 0000 000000 0
NETPark Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Chromition’s complete investors history, request access »